Skip to main content

ADVERTISEMENT

Martino Pepe, MD, PhD

The Novel FlexNav Delivery System for Transcatheter Aortic Valve Implantation With the Portico Device: A Case Series
06/01/2021
We hereby present our preliminary experience with FlexNav in a consecutive series of 18 patients undergoing TAVI with Portico valve in early 2020 (3 with axillary access).
We hereby present our preliminary experience with FlexNav in a consecutive series of 18 patients undergoing TAVI with Portico valve in early 2020 (3 with axillary access).
We hereby present our...
06/01/2021
Journal of Invasive Cardiology
Original Contribution
04/01/2022
The next iteration of drug-eluting stents (DESs) for percutaneous coronary intervention (PCI) has focused on bioresorbable polymers and thin struts. The Alex Plus DES is a new-generation sirolimus-eluting device with 70 µm cobalt chromium...
The next iteration of drug-eluting stents (DESs) for percutaneous coronary intervention (PCI) has focused on bioresorbable polymers and thin struts. The Alex Plus DES is a new-generation sirolimus-eluting device with 70 µm cobalt chromium...
The next iteration of...
04/01/2022
Journal of Invasive Cardiology
Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study
05/01/2021
To learn more about the comparative effectiveness and safety of contemporary TAVI devices, we queried data from the national Italian TAVI registry comparing features, procedural details, and 12-month outcomes of Acurate Neo, Evolut Pro/R,...
To learn more about the comparative effectiveness and safety of contemporary TAVI devices, we queried data from the national Italian TAVI registry comparing features, procedural details, and 12-month outcomes of Acurate Neo, Evolut Pro/R,...
To learn more about the...
05/01/2021
Journal of Invasive Cardiology
Brief Communication
06/08/2021
We hereby present our preliminary experience with FlexNav in a consecutive series of 18 patients undergoing TAVI with Portico valve in early 2020 (3 with axillary access).
We hereby present our preliminary experience with FlexNav in a consecutive series of 18 patients undergoing TAVI with Portico valve in early 2020 (3 with axillary access).
We hereby present our...
06/08/2021
Journal of Invasive Cardiology
Original Contribution
05/06/2022
The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...
The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...
The differential outcomes...
05/06/2022
Journal of Invasive Cardiology